Maternal serum levels of C-reactive protein at early pregnancy to predict fetal growth restriction and preterm delivery: A prospective cohort study.
C-reactive protein
Preterm birth.
Small for gestational age
Journal
International journal of reproductive biomedicine
ISSN: 2476-4108
Titre abrégé: Int J Reprod Biomed
Pays: Iran
ID NLM: 101679102
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
06
03
2019
revised:
03
08
2019
accepted:
23
09
2019
entrez:
21
4
2020
pubmed:
21
4
2020
medline:
21
4
2020
Statut:
epublish
Résumé
A considerable evidence suggests that maternal inflammation dysregulation may play as a risk factor for both maternal and neonatal outcomes. This prospective cohort study was conducted on 120 singleton pregnant women with gestational age less than 20 wk. Maternal CRP serum concentration was measured before 20 wk gestation. Patients were followed-up until the delivery and final outcomes of pregnancy were recorded in terms of preterm delivery and SGA births. Higher maternal serum CRP levels measured early in pregnancy may associate with higher risk of preterm delivery and SGA.
Sections du résumé
BACKGROUND
BACKGROUND
A considerable evidence suggests that maternal inflammation dysregulation may play as a risk factor for both maternal and neonatal outcomes.
MATERIALS AND METHODS
METHODS
This prospective cohort study was conducted on 120 singleton pregnant women with gestational age less than 20 wk. Maternal CRP serum concentration was measured before 20 wk gestation. Patients were followed-up until the delivery and final outcomes of pregnancy were recorded in terms of preterm delivery and SGA births.
CONCLUSION
CONCLUSIONS
Higher maternal serum CRP levels measured early in pregnancy may associate with higher risk of preterm delivery and SGA.
Identifiants
pubmed: 32309764
doi: 10.18502/ijrm.v18i3.6710
pmc: PMC7142318
doi:
Types de publication
Journal Article
Langues
eng
Pagination
157-164Informations de copyright
Copyright © 2020 Nikbakht et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest.
Références
PLoS One. 2017 Aug 16;12(8):e0182731
pubmed: 28813455
Iran J Reprod Med. 2014 Jan;12(1):47-56
pubmed: 24799861
Am J Obstet Gynecol. 2011 May;204(5):415.e1-415.e12
pubmed: 21292229
Cytokine. 2012 Oct;60(1):157-61
pubmed: 22732125
Klin Padiatr. 2013 Mar;225(2):70-74
pubmed: 23526611
Reprod Sci. 2013 Jun;20(6):715-22
pubmed: 23221172
Med Arh. 2010;64(3):132-4
pubmed: 20645502
Am J Reprod Immunol. 2018 Oct;80(4):e13017
pubmed: 29984454
J Matern Fetal Neonatal Med. 2016 Dec;29(24):4065-9
pubmed: 26902393
BJOG. 2013 May;120(6):681-94
pubmed: 23398929
J Exp Med. 2014 Jan 13;211(1):165-79
pubmed: 24395887
Eur J Obstet Gynecol Reprod Biol. 2005 Oct 1;122(2):187-90
pubmed: 16219520
BMC Pregnancy Childbirth. 2018 May 9;18(1):146
pubmed: 29743041
Am J Obstet Gynecol. 2011 Aug;205(2):132.e1-12
pubmed: 21575931
Int J Gynaecol Obstet. 2017 Feb;136(2):145-150
pubmed: 28099729
Am J Obstet Gynecol. 2002 Feb;186(2):268-73
pubmed: 11854648
Front Immunol. 2018 Jun 18;9:1291
pubmed: 29967606
Acta Obstet Gynecol Scand. 2002 May;81(5):424-9
pubmed: 12027816
J Matern Fetal Neonatal Med. 2012 Dec;25(12):2475-8
pubmed: 22900797
Am J Reprod Immunol. 2014 Sep;72(3):326-36
pubmed: 24807462
Am J Obstet Gynecol. 2014 Nov;211(5):509.e1-8
pubmed: 24881826
J Obstet Gynaecol Res. 2010 Oct;36(5):970-7
pubmed: 20722986
Biomed Res Int. 2018 Nov 7;2018:1070151
pubmed: 30533423
Am J Epidemiol. 2005 Dec 1;162(11):1108-13
pubmed: 16236995
Adv Biomed Res. 2014 Jul 31;3:154
pubmed: 25221757
J Proteomics. 2014 Apr 4;100:136-46
pubmed: 24342126